Business
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers
PRINCETON, N.J., November 18, 2025--Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers
About this update from Bristol-myers Squibb Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1497,"height":206,"url":"https://media.zenfs.com/en/business-wire.com/a398f0e776042c9db32b028df935b500"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/VxFRU.yuLsIbiWh6qR5fdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a398f0e776042c9db32b028df935b500","width":960,"height":132},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/V6kBa41jRnEO8yLZsQapWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zMzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a398f0e776042c9db32b028df935b500","width":1200,"height":165}},"lazy":false},{"type":"text","content":"PRINCETON, N.J., November 18, 2025--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) ("Bristol Myers Squibb"), today announced the early participation results, as of 5:00 p.m. (New York City time) on November 17, 2025, (the "Early Tender Deadline") of the previously announced tender offers to purchase for cash its outstanding notes listed in the tables below. Bristol Myers Squibb also announced that it is (i) decreasing the maximum aggregate purchase price of the Pool 1 Notes (as defined below) it will accept for purchase from the previously announced amount of $4,000,000,000 to an amount sufficient (the "Amended Pool 1 Maximum") to accept for purchase all Pool 1 Notes that were validly tendered and not validly withdrawn prior to the Early Tender Deadline and (ii) increasing the maximum aggregate purchase price of the Pool 2 Notes (as defined below) it will accept for purchase from the previously announced amount of $3,000,000,000 to an amount sufficient (the "Amended Pool 2 Maximum") to accept for purchase all Pool 2 Notes with an acceptance priority level at 1 through 4 (as set forth in the second table below) that were validly tendered and not validly withdrawn prior to the Early Tender Deadline as well as up to $250,000,000 in principal amount of Bristol Myers Squibb’s 5.900% Notes due 2033 (the "2033 Notes"). All other terms and conditions of the tender offers as previously announced in the Offer to Purchase, as amended and supplemented hereby, remain unchanged.","length":1550,"tagName":"p"},{"type":"text","content":"The outstanding deb...